An official website of the United States government
Publication Information
Affiliation
Division of Endocrinology, University of Miami, Miami, Florida, USA. jsosenko@med.miami.edu
Authors
Cowie CC, Cuthbertson D, Diabetes Prevention Trial-Type 1 Study Group, Greenbaum CJ, Krischer JP, Mahon J, Palmer JP, Rafkin-Mervis L, Skyler JS, Sosenko JM
Studies
Citation
Sosenko JM, Palmer JP, Rafkin-Mervis L, Krischer JP, Cuthbertson D, Mahon J, Greenbaum CJ, Cowie CC, Skyler JS, Diabetes Prevention Trial-Type 1 Study Group. Incident dysglycemia and progression to type 1 diabetes among participants in the Diabetes Prevention Trial-Type 1. Diabetes Care 2009 Sep;32(9):1603-7. Epub 2009 Jun 1.Abstract
We studied the incidence of dysglycemia and its prediction of the development of type 1 diabetes in islet cell autoantibody (ICA)-positive individuals. In addition, we assessed whether dysglycemia was sustained.